Use of Adjuvant Endocrine Therapy Among Post-Menopausal Breast Cancer Patients in Malaysia

Use of Adjuvant Endocrine Therapy Among Post-Menopausal Breast Cancer Patients in Malaysia

Athirah Saiful Bahri, Tuan Mazlelaa Tuan Mahmood, Siti Azdiah Abdul-Aziz, Mohd Makmor-Bakry, Noraida Mohamed Shah Centre of Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, MalaysiaCorrespondence: Noraida Mohamed ShahCentre of Quality Management of...

Full description

Bibliographic Details
Main Authors:	Saiful Bahri A, Tuan Mahmood TM, Abdul-Aziz SA, Makmor-Bakry M, Mohamed Shah N
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-02-01
Series:	Patient Preference and Adherence
Subjects:	adjuvant endocrine therapy breast cancer interview attitude practice
Online Access:	https://www.dovepress.com/use-of-adjuvant-endocrine-therapy-among-post-menopausal-breast-cancer--peer-reviewed-article-PPA

Similar Items

Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
by: Leah K. Lambert, et al.
Published: (2018-07-01)

Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer
by: Leah K. Lambert, et al.
Published: (2021-04-01)

Does patient health literacy impact adherence to adjuvant endocrine therapy in breast cancer patients?
by: Keim-Malpass J, et al.
Published: (2018-12-01)

Potentially Modifiable Factors Associated with Adherence to Adjuvant Endocrine Therapy among Breast Cancer Survivors: A Systematic Review
by: Kirsti I. Toivonen, et al.
Published: (2021-12-01)

Health belief about adjuvant endocrine therapy in premenopausal breast cancer survivors: a qualitative study
by: Xu L, et al.
Published: (2019-09-01)

Prevalence and determinants of adherence to oral adjuvant endocrine therapy among breast cancer patients in Singapore
by: Eskinder Eshetu Ali, et al.
Published: (2017-01-01)

Both “Vitamin L for Life” and “One Milligram of Satan”: A Multi-Perspective Qualitative Exploration of Adjuvant Endocrine Therapy Use after Breast Cancer
by: Kirsti I. Toivonen, et al.
Published: (2021-07-01)

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence
by: Brett J, et al.
Published: (2018-02-01)

Changes in initiation of adjuvant endocrine therapy for breast cancer after state health reform
by: Kirsten Y. Eom, et al.
Published: (2021-05-01)

Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer
by: Brett J, et al.
Published: (2018-12-01)

Longitudinal Trends in Illness Perception and Depression during Adjuvant Breast Cancer Endocrine Therapy: A Prospective Observational Study
by: Seul Ki Park, et al.
Published: (2021-09-01)

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project
by: Giacomo Pelizzari, et al.
Published: (2018-09-01)

The relationship among psychosocial adaptation, medication adherence and quality of life in breast cancer women with adjuvant endocrine therapy
by: Dong, Y., et al.
Published: (2022)

Adjuvant systemic therapy in older women with breast cancer
by: Leone J, et al.
Published: (2016-07-01)

Are another 5 years of adjuvant aromatase inhibitor therapy needed?
by: Mo QG, et al.
Published: (2016-11-01)

A Survey of Potentially Modifiable Patient-Level Factors Associated with Self-Report and Objectively Measured Adherence to Adjuvant Endocrine Therapies After Breast Cancer
by: Toivonen KI, et al.
Published: (2021-09-01)

Adjuvant CDK4/6 inhibitors combined with endocrine therapy in HR-positive, HER2-negative early breast cancer: A meta-analysis of randomized clinical trials
by: Hong-Fei Gao, et al.
Published: (2021-10-01)

THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer
by: Andrew J. Paladino, et al.
Published: (2019-12-01)

Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis
by: Elizabeth M. Salvo, et al.
Published: (2021-06-01)

Ignoring Adjuvant Toxicity Falsifies the Safety Profile of Commercial Pesticides
by: Robin Mesnage, et al.
Published: (2018-01-01)

Optimizing Expectations About Endocrine Treatment for Breast Cancer: Results of the Randomized Controlled PSY-BREAST Trial
by: Meike C. Shedden-Mora, et al.
Published: (2020-03-01)

The adherence and tolerance of adjuvant endocrine therapy in geriatric breast cancer patients
by: Meng-Ting Peng, et al.
Published: (2016-09-01)

Oncology providers’ perspectives on endocrine therapy prescribing and management
by: Wheeler SB, et al.
Published: (2016-09-01)

Assessing Predictors of Tamoxifen Nonadherence in Patients with Early Breast Cancer
by: Montagna E, et al.
Published: (2021-09-01)

Adjuvant Treatment of Newly Diagnosed Breast Cancer
by: Bossaer, John B., et al.
Published: (2011)

ADJUVANT GOSERELIN IN PRE-MENOPAUSAL PATIENTS WITH EARLY BREAST CANCER: RESULTS FROM THE ZIPP STUDY
by: M. Baum, et al.
Published: (2014-09-01)

Trends in Adjuvant Chemotherapy Use in Endocrine-Sensitive, HER-2 Negative Breast Cancer, With 1 to 3 Positive Nodes: A Single-Centre Study
by: José Manuel Baena Cañada, et al.
Published: (2021-07-01)

Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
by: Cynthia Villarreal-Garza, et al.
Published: (2021-10-01)

Endocrine Disrupting Chemicals: Effects on Endocrine Glands
by: Rosa Lauretta, et al.
Published: (2019-03-01)

Novel strategies to improve the endocrine therapy of breast cancer
by: Aurelio Bartolome Castrellon
Published: (2017-05-01)

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study
by: Gu Ran, et al.
Published: (2012-05-01)

Current feasibility of endocrine therapy for breast cancer
by: I. V. Vysotskaya
Published: (2014-07-01)

Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer
by: Toshihiko Takeiwa, et al.
Published: (2020-05-01)

MODERN VIEWS ON THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF PATIENTS WITH HORMONE-DEPENDENT BREAST CANCER: SABCS-2017 NEWS
by: A. A. Bozhok
Published: (2018-04-01)

Comparison of distress in breast cancer survivors treated with different adjuvant endocrine therapies: a single-centre cross-sectional study
by: Tulay Kus, et al.
Published: (2017-07-01)

Effects of supervised exercise during adjuvant endocrine therapy in overweight or obese patients with breast cancer: The I-MOVE study
by: Harm L. Ormel, et al.
Published: (2021-08-01)

Women’s coping strategies during the first three months of adjuvant endocrine therapy for breast cancer
by: Susanne Ahlstedt Karlsson, et al.
Published: (2020-03-01)

A view on endocrine surgery as the new specialty
by: Dmitriy Germanovich Bel'tsevich, et al.
Published: (2015-05-01)

Metastatic breast cancer: Endocrine therapy landscape reshaped
by: Mohamad Adham Salkeni, et al.
Published: (2017-10-01)

Adherence status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and its influencing factors: A cross‐sectional survey
by: Hui Xu, et al.
Published: (2020-06-01)